News & Updates

Show Multimedia Only

Awareness, linkage to care may motivate people with HCV to seek treatment

05 Aug 2025 by

Nearly one in five hepatitis C virus (HCV) infections in the last decade have been treated with direct-acting antivirals (DAAs), as well as about a third of the target population, according to a study.

Awareness, linkage to care may motivate people with HCV to seek treatment

05 Aug 2025

No excess liver cancer risk seen with oral contraceptive use

03 Aug 2025 by

Two large prospective cohorts show no evidence of an association between the use of oral contraceptives and the risk of liver cancer.

No excess liver cancer risk seen with oral contraceptive use

03 Aug 2025

First-line NUC-1031/cisplatin trial for advanced BTC cut short due to futility

24 Jul 2025

A recent phase III trial of NUC-1031/cisplatin has been terminated early due to ineffectiveness as first-line treatment for advanced biliary tract cancer (BTC).

First-line NUC-1031/cisplatin trial for advanced BTC cut short due to futility

24 Jul 2025

High-fat dairy ups risk of liver disease mortality, cancer

21 Jul 2025

Individuals who regularly consume high-fat dairy are at greater risk of death due to chronic liver diseases (CLD), reveals a recent study. However, low-fat dairy intake may lower such risk.

High-fat dairy ups risk of liver disease mortality, cancer

21 Jul 2025

Hepatic steatosis linked to lower mortality in CLD patients

16 Jul 2025

The presence of substantial hepatic steatosis estimated by controlled attenuated parameter (CAP) score among patients who underwent vibration-controlled transient elastography (VCTE) appears to reduce the risk of all-cause mortality and decompensation, particularly in those with metabolic dysfunction-associated steatotic liver disease (MASLD), reports a study.

Hepatic steatosis linked to lower mortality in CLD patients

16 Jul 2025

SGLT-2 inhibitors may provide liver-related benefits to patients with cirrhosis

09 Jul 2025 by

The use of a sodium-glucose cotransporter 2 (SGLT-2) inhibitor helps lower the incidence of serious liver events among patients with cirrhosis who are receiving diuretic therapy, according to a study.

SGLT-2 inhibitors may provide liver-related benefits to patients with cirrhosis

09 Jul 2025

CDK4/6 inhibitor-induced liver injury common in breast cancer

05 Jul 2025 by

Liver injury occurs in around one in 20 patients treated with cyclin-dependent kinase 4/6 inhibitors for metastatic breast cancer, according to a multicentre retrospective study in Spain.

CDK4/6 inhibitor-induced liver injury common in breast cancer

05 Jul 2025

ALT helps spot liver fibrosis in overweight children

05 Jul 2025

Alanine aminotransferase (ALT) appears to be a useful primary screening measure to identify early signs of fibrosis, such as increased liver stiffness, in children with overweight or obesity and additional risk factors, according to a study.

ALT helps spot liver fibrosis in overweight children

05 Jul 2025

FMT prevents hepatic encephalopathy recurrence in cirrhosis

30 Jun 2025 by

A phase II study has demonstrated the safety of faecal microbiota transplantation (FMT) in patients with cirrhosis treated with lactulose and rifaximin, with no related adverse events (AEs) seen. FMT also results in lower rates of hepatic encephalopathy (HE) recurrence.

FMT prevents hepatic encephalopathy recurrence in cirrhosis

30 Jun 2025

Diabetes in CHD patients ups risk of hepatocellular carcinoma

26 Jun 2025 by

The presence of diabetes mellitus predisposes patients with chronic hepatitis B (CHB) to a higher risk of developing hepatocellular carcinoma (HCC), reveals a study presented at EASL 2025.

Diabetes in CHD patients ups risk of hepatocellular carcinoma

26 Jun 2025

News & Updates

Showing Hepatology articles

Showing

Specialty:

Awareness, linkage to care may motivate people with HCV to seek treatment

Awareness, linkage to care may motivate people with HCV to seek treatment

No excess liver cancer risk seen with oral contraceptive use

No excess liver cancer risk seen with oral contraceptive use

First-line NUC-1031/cisplatin trial for advanced BTC cut short due to futility

First-line NUC-1031/cisplatin trial for advanced BTC cut short due to futility

High-fat dairy ups risk of liver disease mortality, cancer

High-fat dairy ups risk of liver disease mortality, cancer

Hepatic steatosis linked to lower mortality in CLD patients

Hepatic steatosis linked to lower mortality in CLD patients

SGLT-2 inhibitors may provide liver-related benefits to patients with cirrhosis

SGLT-2 inhibitors may provide liver-related benefits to patients with cirrhosis

CDK4/6 inhibitor-induced liver injury common in breast cancer

CDK4/6 inhibitor-induced liver injury common in breast cancer

ALT helps spot liver fibrosis in overweight children

ALT helps spot liver fibrosis in overweight children

FMT prevents hepatic encephalopathy recurrence in cirrhosis

FMT prevents hepatic encephalopathy recurrence in cirrhosis

Diabetes in CHD patients ups risk of hepatocellular carcinoma

Diabetes in CHD patients ups risk of hepatocellular carcinoma